title: Age at onset determines severity and choice of treatment in early rheumatoid arthritis: a prospective study.
abstract: BACKGROUND
  Disease activity, severity and comorbidity contribute to increased mortality in patients with rheumatoid arthritis (RA). We evaluated the impact of age at disease onset on prognostic risk factors and treatment in patients with early disease.
  
  
  METHODS
  In this study, 950 RA patients were followed regularly from the time of inclusion (<12 months from symptom onset) for disease activity (erythrocyte sedimentation rate (ESR), C-reactive protein (CRP), tender and/or swollen joints, Visual Analogue Scale pain and global scores, and Disease Activity Score in 28 joints (DAS28)) and function (Health Assessment Questionnaire (HAQ)). Disease severity, measured on the basis of radiographs of the hands and feet (erosions based on Larsen score), extraarticular disease, nodules, and comorbidities and treatment (disease-modifying antirheumatic drugs (DMARDs), corticosteroids, biologics and nonsteroidal anti-inflammatory drugs) were recorded at the time of inclusion and at 5 years. Autoantibodies (rheumatoid factor, antinuclear antibodies and antibodies against cyclic citrullinated peptides (ACPAs)) and genetic markers (human leucocyte antibody (HLA) shared epitope and protein tyrosine phosphatase nonreceptor type 22 (PTPN22)) were analysed at the time of inclusion. Data were stratified as young-onset RA (YORA) and late-onset RA (LORA), which were defined as being below or above the median age at the time of onset of RA (58 years).
  
  
  RESULTS
  LORA was associated with lower frequency of ACPA (P < 0.05) and carriage of PTPN22-T variant (P < 0.01), but with greater disease activity at the time of inclusion measured on the basis of ESR (P < 0.001), CRP (P < 0.01) and accumulated disease activity (area under the curve for DAS28 score) at 6 months (P < 0.01), 12 months (P < 0.01) and 24 months (P < 0.05), as well as a higher HAQ score (P < 0.01) compared with YORA patients. At baseline and 24 months, LORA was more often associated with erosions (P < 0.01 for both) and higher Larsen scores (P < 0.001 for both). LORA was more often treated with corticosteroids (P < 0.01) and less often with methotrexate (P < 0.001) and biologics (P < 0.001). YORA was more often associated with early DMARD treatment (P < 0.001). The results of multiple regression analyses supported our findings regarding the impact of age on chosen treatment.
  
  
  CONCLUSIONS
  YORA patients were more frequently ACPA-positive than LORA patients. LORA was more often associated with erosions, higher Larsen scores, higher disease activity and higher HAQ scores at baseline. Nevertheless, YORA was treated earlier with DMARDs, whilst LORA was more often treated with corticosteroids and less often with DMARDs in early-stage disease. These findings could have implications for the development of comorbidities.
authors.forename: Lena
authors.initials: L
authors.lastname: Innala
authors.forename: Ewa
authors.initials: E
authors.lastname: Berglin
authors.forename: Bozena
authors.initials: B
authors.lastname: Möller
authors.forename: Lotta
authors.initials: L
authors.lastname: Ljung
authors.forename: Torgny
authors.initials: T
authors.lastname: Smedby
authors.forename: Anna
authors.initials: A
authors.lastname: Södergren
authors.forename: Staffan
authors.initials: S
authors.lastname: Magnusson
authors.forename: Solbritt
authors.initials: S
authors.lastname: Rantapää-Dahlqvist
authors.forename: Solveig
authors.initials: S
authors.lastname: Wållberg-Jonsson
mesh_terms: D000293:Adolescent; D000328:Adult; D017668:Age of Onset; D000368:Aged; D000369:Aged, 80 and over; D018501:Antirheumatic Agents / Q000627:therapeutic use*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy* / Q000453:epidemiology* / Q000503:physiopathology*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D012042:Registries; D055815:Young Adult
chemical_list: D018501:Antirheumatic Agents
references.citation: Br Med J. 1974 Mar 9;1(5905):444-6
references.pmid: 4131601
references.citation: Arthritis Rheum. 2008 Dec 15;59(12):1690-7
references.pmid: 19035419
references.citation: J Rheumatol. 1997 Mar;24(3):445-51
references.pmid: 9058647
references.citation: Drugs Aging. 2009;26(9):739-50
references.pmid: 19728748
references.citation: Ann Rheum Dis. 2007 Jan;66(1):70-5
references.pmid: 16877533
references.citation: Rheum Dis Clin North Am. 2007 Feb;33(1):57-70
references.pmid: 17367692
references.citation: Rheumatology (Oxford). 1999 Mar;38(3):228-34
references.pmid: 10325661
references.citation: J Rheumatol. 1991 Sep;18(9):1285-9
references.pmid: 1757926
references.citation: Ann Rheum Dis. 2010 Jun;69(6):964-75
references.pmid: 20444750
references.citation: Ann Rheum Dis. 2007 Mar;66(3):389-93
references.pmid: 16950810
references.citation: Isr J Med Sci. 1966 Sep-Oct;2(5):607-13
references.pmid: 5970647
references.citation: BMJ. 1990 Jan 27;300(6719):230-5
references.pmid: 2106931
references.citation: Arthritis Res Ther. 2004;6(4):R303-8
references.pmid: 15225365
references.citation: Arthritis Res Ther. 2011 Aug 15;13(4):R131
references.pmid: 21843325
references.citation: Rheumatology (Oxford). 2003 Feb;42(2):268-75
references.pmid: 12595621
references.citation: Clin Exp Rheumatol. 2008 Sep-Oct;26(5 Suppl 51):S35-61
references.pmid: 19026144
references.citation: Arthritis Rheum. 2002 Apr;46(4):894-8
references.pmid: 11953964
references.citation: Arthritis Rheum. 2003 Apr;48(4):917-26
references.pmid: 12687533
references.citation: J Rheumatol. 2004 Dec;31(12):2366-73
references.pmid: 15570636
references.citation: Best Pract Res Clin Rheumatol. 2009 Feb;23(1):93-102
references.pmid: 19233049
references.citation: Clin Rheumatol. 2005 Sep;24(5):485-9
references.pmid: 15750680
references.citation: Arthritis Res Ther. 2006;8(1):R19
references.pmid: 16507117
references.citation: Cochrane Database Syst Rev. 2007 Jan 24;(1):CD006356
references.pmid: 17253590
references.citation: Lancet. 2010 Sep 25;376(9746):1094-108
references.pmid: 20870100
references.citation: Arthritis Care Res (Hoboken). 2013 May;65(5):832-3
references.pmid: 23097242
references.citation: Am J Med. 2001 Oct 15;111(6):446-51
references.pmid: 11690569
references.citation: Clin Exp Rheumatol. 1984 Apr-Jun;2(2):157-61
references.pmid: 6532620
references.citation: Arthritis Rheum. 2007 Jun;56(6):1754-64
references.pmid: 17530704
references.citation: J Rheumatol. 1995 Oct;22(10):1974-5
references.pmid: 8992003
references.citation: J Rheumatol. 2000 Jul;27(7):1632-7
references.pmid: 10914843
references.citation: N Engl J Med. 2004 Jun 17;350(25):2591-602
references.pmid: 15201416
references.citation: Ann Rheum Dis. 2006 Sep;65(9):1226-9
references.pmid: 16414968
references.citation: Ann Intern Med. 2007 Jun 5;146(11):797-808
references.pmid: 17548411
references.citation: Arthritis Res Ther. 2007;9(3):R56
references.pmid: 17553139
references.citation: Arthritis Rheum. 1988 Mar;31(3):315-24
references.pmid: 3358796
references.citation: Acta Rheumatol Scand. 1957;3(3):249-58
references.pmid: 13478515
references.citation: Clin Exp Rheumatol. 2013 Mar-Apr;31(2):256-62
references.pmid: 23305590
references.citation: Rheumatology (Oxford). 2009 Aug;48(8):906-10
references.pmid: 19478038
references.citation: Geriatrics. 1970 Feb;25(2):103-13
references.pmid: 4189224
references.citation: Arthritis Rheum. 1998 Oct;41(10):1845-50
references.pmid: 9778226
references.citation: Arthritis Care Res (Hoboken). 2011 Dec;63(12):1745-52
references.pmid: 22127966
references.citation: Arthritis Rheum. 2004 Jul;50(7):2072-81
references.pmid: 15248204
references.citation: Scand J Rheumatol. 1988;17(4):263-71
references.pmid: 3187457
references.citation: Arthritis Rheum. 2000 Jan;43(1):22-9
references.pmid: 10643696
references.citation: Arthritis Rheum. 1995 Jan;38(1):44-8
references.pmid: 7818570
references.citation: Ann Rheum Dis. 2006 Apr;65(4):453-8
references.pmid: 16176994
references.citation: Ann Rheum Dis. 2009 Apr;68(4):508-13
references.pmid: 18420939
references.citation: Arthritis Rheum. 1984 Aug;27(8):864-72
references.pmid: 6431998
references.citation: Arthritis Rheum. 2007 Aug 15;57(6):928-34
references.pmid: 17665462
references.citation: J Rheumatol. 2003 Apr;30(4):691-6
references.pmid: 12672185
references.citation: Rheumatology (Oxford). 2006 Dec;45(12):1555-7
references.pmid: 16690762
references.citation: Ann Rheum Dis. 2010 Jun;69(6):1010-4
references.pmid: 20448288
references.citation: Ann Intern Med. 1996 Apr 15;124(8):699-707
references.pmid: 8633829